Cargando…

Editorial: Neurological, Metabolic and Inflammatory Disorders: A Common Root in Inflammasome

Detalles Bibliográficos
Autores principales:	Pellegrini, Carolina, Antonioli, Luca, Lopez-Castejon, Gloria, Bertinaria, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689136/ https://www.ncbi.nlm.nih.gov/pubmed/34950043 http://dx.doi.org/10.3389/fphar.2021.808400

Ejemplares similares

A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2018)

Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
por: Pellegrini, Carolina, et al.
Publicado: (2019)

Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2017)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Inflammasome Inhibitors
por: Bertinaria, Massimo
Publicado: (2021)

Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention
por: Colucci, Rocchina, et al.
Publicado: (2018)

Editorial: Metabolic and Neurological Modulation by Glucosinolates, Isothiocyanates, and Terpenes to Improve Health
por: González-Trujano, M. E., et al.
Publicado: (2022)

Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2021)

Editorial: Restoring endoplasmic reticulum proteostasis to treat neurological disorders
por: Medinas, Danilo B., et al.
Publicado: (2023)

The inflammasomes, immune guardians at defence barriers
por: Palazon‐Riquelme, Pablo, et al.
Publicado: (2018)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

Emerging trends and hot spots of NLRP3 inflammasome in neurological diseases: A bibliometric analysis
por: Yu, Xiaoyan, et al.
Publicado: (2022)

Editorial: Erythropoietin and Its Analogues as Therapeutics for Neurological Diseases
por: Brines, Michael, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Natural products based management of neurological disorders: Mechanistic insight and translational informatics approach
por: Kumar, Suresh, et al.
Publicado: (2023)

Editorial: Role of Blood Cells in Inflammatory and Vascular Disorders
por: Brancaleone, Vincenzo, et al.
Publicado: (2020)

Editorial: Probiotics and its Effects on Inflammatory and Infectious Disorders
por: de Castro Soares, Siomar, et al.
Publicado: (2022)

NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury
por: Savage, Catherine Diane, et al.
Publicado: (2012)

Role of Resolvins in the Inflammatory Resolution of Neurological Diseases
por: Li, Chunrong, et al.
Publicado: (2020)

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
por: Hashimoto, Kenji
Publicado: (2019)

Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders
por: Ayaz, Muhammad, et al.
Publicado: (2019)

Editorial: Establishing Genetic Pleiotropy to Identify Common Pharmacological Agents for Common Diseases
por: O’Mara, Tracy A., et al.
Publicado: (2019)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

From kitchen to clinic: Pharmacotherapeutic potential of common spices in Indian cooking in age-related neurological disorders
por: Norouzkhani, Narges, et al.
Publicado: (2022)

Editorial: New trends in natural product research for inflammatory and infectious diseases
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2022)

Yupingfeng San Inhibits NLRP3 Inflammasome to Attenuate the Inflammatory Response in Asthma Mice
por: Liu, Xue, et al.
Publicado: (2017)

Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
por: Fenini, Gabriele, et al.
Publicado: (2017)

NLRP3 inflammasome triggers interleukin‐37 release from human monocytes
por: Gritsenko, Anna, et al.
Publicado: (2022)

Editorial: Emerging talents in Frontiers in Pharmacology: Drug metabolism and transport 2022
por: Hinds, Terry D., et al.
Publicado: (2022)

Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
por: Su, Chia-Cheng, et al.
Publicado: (2021)

Editorial: Sex Differences in Inflammatory Diseases
por: Trabace, Luigia, et al.
Publicado: (2022)

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2023)

Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders
por: Vasconcelos, Andrea Rodrigues, et al.
Publicado: (2019)

Jinmaitong Alleviates Diabetic Neuropathic Pain Through Modulation of NLRP3 Inflammasome and Gasdermin D in Dorsal Root Ganglia of Diabetic Rats
por: Sun, Qing, et al.
Publicado: (2021)

Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets
por: Zhao, Jia, et al.
Publicado: (2023)

Editorial: Traditional medicine and chronic inflammatory diseases
por: Liu, Wei, et al.
Publicado: (2023)

Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications
por: Tsai, Fuu-Jen, et al.
Publicado: (2018)

Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2021)

Hematopoietic Cell Kinase (HCK) Is Essential for NLRP3 Inflammasome Activation and Lipopolysaccharide-Induced Inflammatory Response In Vivo
por: Kong, Xiangxi, et al.
Publicado: (2020)

Editorial: Assessing the Pharmacological Effects and Therapeutic Potential of Traditional Chinese Medicine in Neurological Disease Models: An Update
por: Deng, Zhiqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5rts6nv3k0kpk1hpkoa37p5c7